Effect of somatostatin analogue (SMS 201-995, sandostatin) on pancreatic secretion in humans
- 1 May 1987
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 82 (5) , 49-54
- https://doi.org/10.1016/0002-9343(87)90426-8
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Effect of a New Somatostatin Analogue on Pancreatic Function in Healthy VolunteersPancreas, 1986
- Exocrine Pancreatic Function in Oleic Acid-Induced Pancreatic Insufficiency in RatsPancreas, 1986
- Long-Term Treatment of Patients with Endocrine Gastrointestinal Tumours with the Somatostatin Analogue SMS 201-995Scandinavian Journal of Gastroenterology, 1986
- Short-Term Administration of the Somatostatin Analogue SMS 201-995 in Patients with Carcinoid TumoursScandinavian Journal of Gastroenterology, 1986
- SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged actionLife Sciences, 1982
- Effects of Somatostatin on Gastrointestinal Propagation and Absorption of Oral Glucose in ManDigestion, 1980
- Effect of intravenous somatostatin on jejunal absorption of glucose, amino acids, water, and electrolytesGastroenterology, 1980
- Release of Gastric Inhibitory Polypeptide (GIP) by Intraduodenal Acidification in Rats and Humans and Abolishment of the Incretin Effect of Acid by GIP-Antiserum in RatsGastroenterology, 1979
- Über die radioimmunologische Bestimmung von Insulin im BlutKlinische Wochenschrift, 1965
- Pancreatic Exocrine Function in Neoplastic and Inflammatory Disease; A Simple and Reliable New TestGastroenterology, 1962